ALX-210-315-R100 | PAb to Cannabinoid Receptor 2 (human) | | 100 ul |
ALX-210-198-1 | PAb to Cannabinoid Receptor 2 | | 1 Vial |
ALX-210-317-R100 | PAb to Cannabinoid Receptor 2 | | 100 ul |
BXT-C103620-4 | Cannabinoid Receptor 1 (human) (MRPgradeTM) | | 4x50 Units |
BXT-C103720-4 | Cannabinoid Receptor 2 (human) (MRPgradeTM) | | 4x50 Units |
| | | |
ALX-201-173-C100 | Midkine (human) (rec.) (His) | | 100 ug |
ALX-201-174-C100 | Osteoblast Specific Factor 1 (human) (rec.) | | 100 ug |
ALX-201-175-C100 | Osteoblast Specific Factor 2 (human) (rec.) | | 100 ug |
ALX-210-397-C050 | PAb to Midkine (human) | | 50 ug |
ALX-210-398-C050 | PAb to Osteoblast Specific Factor 1 (human) | | 50 ug |
ALX-210-399-C050 | PAb to Osteoblast Specific Factor 2 (human) | | 50 ug |
ALX-804-465-C100 | MAb to CCL2 (human) (5D3-F7) | | 100 ug |
ALX-804-594-C100 | MAb to CCL2 (human) (5J.1) | | 100 ug |
ALX-804-549-C100 | MAb to CCL2 (human) (D9) | | 100 ug |
| | | |
AG-RC05H3EK-KI01 | RBP4 (human) ELISA Kit | | 1 Kit |
AG-V0523EK-KI01 | Visfatin (human) ELISA Kit | NEW | 1 Kit |
ALX-201-319-C050 | Visfatin, Soluble (human) (rec.) (His) | | 50 ug |
ALX-201-336-C010 | Visfatin, Soluble (human) (rec.) | | 10 ug |
ALX-201-336-C050 | Visfatin, Soluble (human) (rec.) | | 50 ug |
ALX-201-318-C050 | Visfatin, Soluble (mouse) (rec.) (His) | | 50 ug |
ALX-201-332-C050 | Visfatin, Soluble (rat) (rec.) (His) | | 50 ug |
ALX-850-064-KI01 | CD40L, Soluble (human) (rec.) (Set) | | 1 Set |
ALX-522-015-2010 | CD40L, Soluble (human) (rec.) | | 2x10 ug |
ALX-522-015-6010 | CD40L, Soluble (human) (rec.) (SuperPackTM) | | 6x10 ug |
ALX-522-076-C010 | Fc (human):CD40L (human), Soluble (rec.) | | 10 ug |
ALX-522-072-C010 | Fc (human):CD40L (mouse), Soluble (rec.) | | 10 ug |
ALX-522-070-2010 | CD40L, Soluble (mouse) (rec.) | | 2x10 ug |
ALX-850-075-KI01 | CD40L, Soluble (mouse) (rec.) Set | | 1 Set |
ALX-522-098-C010 | IL-33, Soluble (human) (rec.) | NEW | 10 ug |
ALX-522-101-C010 | IL-33, Soluble (mouse) (rec.) | NEW | 10 ug |